Applied Therapeutics, Inc.
APLT
$0.3987
$0.00040.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -105.62M | -187.31M | -161.09M | -193.56M | -119.76M |
| Total Depreciation and Amortization | 426.00K | 352.00K | 366.00K | 360.00K | 354.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.37M | 106.38M | 93.59M | 129.49M | 65.68M |
| Change in Net Operating Assets | 2.52M | -1.26M | -6.10M | -3.38M | -1.44M |
| Cash from Operations | -84.31M | -81.84M | -73.24M | -67.09M | -55.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 13.87M |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 13.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -311.00K | -776.00K | -1.24M | -1.55M | -1.86M |
| Issuance of Common Stock | 115.81M | 145.72M | 162.75M | 190.66M | 74.85M |
| Repurchase of Common Stock | -1.69M | -1.69M | -1.69M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 1.55M | 1.55M |
| Cash from Financing | 113.81M | 143.25M | 159.82M | 190.66M | 74.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.50M | 61.41M | 86.58M | 123.57M | 33.24M |